OTC Watch

All stocks / ISCO

International Stem Cell CORP ISCO

International Stem Cell (ISCO): 2 insider sales or sale notices in 90 days and the latest annual figures in plain language. Each fact links to its SEC filing.

Insider sellingEstimated float OTCQBCalifornia, USA
Live quote on OTC Markets

Market listing

Full name
INTERNATIONAL STEM CELL CORPORATION
Market tier
OTCQB
Trading status
Active
Last trade
Nov 16
Website
www.internationalstemcell.com
Source: Stockwatch, 2026-11-17

The financial report, and what it means

Annual figures to 2025-12-31
The report says
Revenue
$9,100,000
Net loss
($418,000)
What it means

It spends more than it earns

Under strain

Customers paid it $9.1 million in the year. It lost $418,000. For every $1 that came in, about $1.05 went out.

The report says
Cash and cash equivalents
$993,000
Net cash from operating activities
$8,000
What it means

The business brings in cash

Steady

Day-to-day business added $8,000 in cash over the year. It had $993,000 in the bank.

The report says
Total assets
$4,819,000
Total liabilities
$4,579,000
What it means

It owns more than it owes

Steady

Everything the company owns adds up to $4.8 million. Its debts and unpaid bills add up to $4.6 million. That is about $0.95 owed for every $1 owned.

What this adds up to

1 of 3 checks show strain. It spends more than it earns. These are facts from the company's own reports, not a recommendation.

Signals

Insider selling2026-09-11

MAIER PAUL V reported selling 32,802 shares for about $10,497 (Form 4, 2026-09-11).

Rule: Form 4 or Form 144 sale in the last 90 days. Source record

Insider selling2026-09-11

MAIER PAUL V filed notice of a proposed sale of 32,802 shares (Form 144, 2026-09-11).

Rule: Form 4 or Form 144 sale in the last 90 days. Source record

Estimated float2026-08-11

Estimated float about 8,004,389 shares as of 2026-08-11: 8,004,389 outstanding minus 0 held by 1 reporting insider(s).

Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record

Shares outstanding

Source: SEC filings
2025-09-30
8.0M
2025-11-07
8.0M
2025-12-31
8.0M
2026-03-25
8.0M
2026-03-31
8.0M
2026-05-11
8.0M
2026-06-30
8.0M
2026-08-11
8.0M

Price chart

Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets

Recent filings

2026-09-17 4
2026-09-15 4
2026-09-11 144
2026-09-08 8-KFORM 8-K
2026-08-13 10-Q10-Q
2026-08-04 DEF 14CDEFINITIVE INFORMATION STATEMENT
2026-07-24 PRE 14CPRELIMINARY INFORMATION STATEMENT
2026-07-16 8-KCURRENT REPORT
2026-06-23 4
2026-06-23 4
2026-06-12 8-KCURRENT REPORT
2026-05-14 10-Q10-Q

Common questions about ISCO

Does ISCO file reports with the SEC?

Yes. International Stem Cell files with the SEC under company number 0001355790. The most recent filing we hold is a 4 dated 2026-09-17.

Source record

How many ISCO shares are outstanding?

8,004,389 shares as of 2026-08-11, as reported to the SEC.

Source record

Has ISCO filed reports late?

We found no late-filing notices (NT 10-K or NT 10-Q) in its last 12 months of SEC filings.

Have ISCO insiders sold shares recently?

2 insider sales or sale notices were filed in the last 90 days. Most recent: MAIER PAUL V reported selling 32,802 shares for about $10,497 (Form 4, 2026-09-11).

Source record

Is International Stem Cell making money?

Customers paid it $9.1 million in the year. It lost $418,000. For every $1 that came in, about $1.05 went out. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)

Source record